Subject: RXMD Announces Another Record Revenue Month for October

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Announces Another Record Revenue Month for October
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.0645

Change (%): + 0.001 (1.57)

Volume: 26,000
RXMD Chart

Progressive Care Inc. Announces Record-Breaking October 2018

MIAMI, Nov. 16, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and record-breaking number of prescriptions filled for October 2018.

In October, the company reported a total of $1.9 million in net revenue, a 10% increase from the same month last year, and a 30% increase in prescriptions filled during the same month last year, totaling more than 31,000 prescriptions filled.

Progressive Care’s wholly owned subsidiary PharmCo, LLC reported a 30% increase in prescriptions filled over the same month last year, totaling more than 28,300 prescriptions. The company’s newest PharmCo facility, Touchpoint Rx (dba PharmCo Rx 1002), reported 2700 prescriptions filled during the month of October and nearly $100,000 in revenue.

“We are delighted to announce a record-breaking increase in prescriptions filled in October, which defies the trend many other pharmacies are seeing right now,” said S. Parikh Mars, CEO of Progressive Care. “October also saw the noteworthy beta launch of our proprietary tele-pharmacy platform, Tele-PharmCo, which we trust will revolutionize the way pharmacies connect with patients, and we couldn’t be more thrilled to begin rolling the platform out in hospital kiosks and clinics during the coming months. We are committed to making patient experiences as personalized and efficient as possible, and look forward to continue building out our technology offering through the rest of 2018 and into 2019. We trust our high standards for patient service and diverse range of services offered will lead to continued growth and many more record-breaking months to come.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks